Treatment for Myeloproliferative Disorders

Emerging Role of MDM2 in Myelofibrosis Care

What is MDM2 and what does it mean for myelofibrosis patients? Watch as Dr. Srdan Verstovsek explains the mechanism of action of the MDM2 inhibitor and which patient population it may benefit.

Published:

MPN Researcher Shares Optimism for Future Treatment

Expert Dr. Jason Gotlib gives an overview of the progress to improve treatment durability and efficacy for MPN patients. Watch now to learn his expert knowledge.

Published:

Can Hypomethylating Agents Be Used for MPNs?

What are hypomethylating agents, and can MPN patients benefit from them? Watch as Dr. Guillermo Garcia-Manero discusses studies on them for MPN treatment.

Published:

Experts Explain MDM2 Inhibition and Clinical Trial for MPN Patients

How does MDM2 inhibition work to treat MPNs? Watch as experts Dr. Srdan Verstovsek and Dr. Jason Gotlib discuss an upcoming MDM2 inhibitor clinical trial for patients living with MF and PV.

Published:

Exclusive Coverage of MDM2 Inhibition: Which MPN Patients Will Benefit?

Cancer researchers identified a promising new target for inhibitor treatment in MPNs – MDM2 – which may allow the cancer cell suppressor gene P53 to reactivate. Watch now to learn more.

Published:

ASCO 2019: Noted MPN Expert Shares Key Takeaways for Patients

Leading MPN expert Dr. Ruben Mesa gives clinical trial data updates for MPNs and insight to where treatment research is headed. Watch now to learn more.

Published:

Prioritizing Patients: Dr. Pemmaraju’s MPN Highlights From ASCO 2019

How are researchers going beyond the breakthroughs in cancer care? Watch as Dr. Naveen Pemmaraju discusses MPN treatment developments from ASCO 2019.

Published:

Key Tips on How to Approach MPN Treatment Decisions

How can patients feel confident about their MPN care? Watch as MPN expert Dr. Srdan Verstovsek and patient advocates share advice for approaching treatment decisions.

Published:

Will CAR T-Cell Therapy Work for Solid Tumor Cancers?

Is CAR T-cell therapy on the horizon for patients with solid tumor cancers? Watch as Dr. David Maloney discusses advances in CAR-T research, current clinical studies, treatment efficacy and more.

Published:

Showing 9 of 214 programs
Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on June 19, 2019